Organizer
Thermo Fisher Scientific
Thermo Fisher Scientific
A unique company dedicated to serving science helping our customers drive productivity and accelerate results. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services.
Tags
LC/MS
LC/MS/MS
LC/Orbitrap
LC/HRMS
LinkedIn Logo

Toward early detection of congenital disease using Orbitrap Astral DIA MS/MS

RECORD | Already taken place Th, 26.2.2026
Learn how Orbitrap Astral MS in DIA mode enables ultra-sensitive detection of parasite-specific IgG variants to improve early diagnosis of congenital toxoplasmosis.
Go to the webinar
Thermo Fisher Scientific: Omics innovations for the biopharmaceutical industry
Thermo Fisher Scientific: Omics innovations for the biopharmaceutical industry

This presentation describes a proof-of-concept mass spectrometry strategy to improve early diagnosis of congenital toxoplasmosis by distinguishing maternal and newborn immune responses. The work focuses on detecting IgG polymorphisms specific to Toxoplasma gondii using advanced LC-MS approaches, with particular emphasis on the Thermo Scientific Orbitrap Astral MS operated in DIA mode. Current diagnostic methods struggle to confirm fetal infection due to low parasite burden and the presence of maternal IgG in newborns. To address this, the team developed workflows to purify IgG subclasses, target parasite-specific antibodies, and identify subtle sequence variants differing by only one or two amino acids. While middle-down approaches lacked sensitivity for parasite-specific IgG, bottom-up DIA on the Thermo Scientific Orbitrap Astral MS enabled detection of low-abundance, discriminating peptides. Manual validation and fragment correlation were critical to eliminate false positives caused by high sequence homology. Overall, the study demonstrates Astral’s sensitivity and DIA capability for tackling extremely challenging, clinically relevant immunoproteomics problems.

Learning points:

  • Congenital toxoplasmosis diagnosis requires discrimination between maternal and newborn IgG
  • Orbitrap Astral MS DIA enables detection of ultra-low-abundance, polymorphic IgG peptides
  • Manual validation remains essential when analyzing highly homologous antibody sequences

Who should attend?

  • Researchers in clinical proteomics and infectious disease diagnostics
  • Scientists studying antibody polymorphisms, immunoproteomics, or neonatal immunity
  • Mass spectrometry experts interested in DIA strategies for extreme sensitivity challenges

This webinar is a recording from the Omics innovations for the biopharmaceutical industry seminar on December 11, 2025 in Strasbourg.

Cannot attend on February 26? Please register anyway to automatically receive access to the recording.

Presenter: Joëlle Vinh (Head of SMBP CNRS Biological MS and Proteomics Lab, ESPCI Paris)

Thermo Fisher Scientific
LinkedIn Logo
 

Related content

Oligonucleotide Analysis Using the Agilent InfinityLab Pro iQ and Altura Oligo HPH-C18 Column

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/SQ, Consumables, LC columns
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma

Simultaneous Quantitation and Discovery analysis: Combining targeted and untargeted metabolomics on Orbitrap mass spectrometers

Applications
| 2026 | Thermo Fisher Scientific
Instrumentation
LC/MS, LC/MS/MS, LC/Orbitrap, LC/HRMS
Manufacturer
Thermo Fisher Scientific
Industries
Metabolomics

Analysis of Per- and Polyfluoroalkyl Substances (PFAS) in Wastewater

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Agilent Technologies
Industries
Environmental

Non-Targeted Screening of Biosolids with the Xevo™ MRT Mass Spectrometer Reveals New Isoforms of PFAS

Applications
| 2026 | Waters
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Waters
Industries
Environmental

High Resolution Characterization of Lipid Nanoparticles Using the Xevo™ Charge Detection Mass Spectrometry (CDMS) Instrument - Single Particle Mass Analysis of Intact LNP-mRNA Formulations

Applications
| 2026 | Waters
Instrumentation
LC/MS, LC/MS/MS, LC/HRMS, Particle characterization, LC/IT
Manufacturer
Waters
Industries
Lipidomics
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike